Live Demo
SITE 214 · --:--:-- EDT Back to protocolscribe.com
2041
0017
Protocol PS-2041 · Phase II · Oncology (example use case)

Subject 2041-0017 · open sheet: Cycle 1, Day 1

Cohort3 · 40 mg/m²
InvestigatorDr. A. Okafor
C1D1 date19-Jul-2026
EnvironmentDemo data

Cycle 1 · Activities

Patient study milestones — select a step to open its sheet

On schedule
Screening05-Jul-2026
C1D119-Jul-2026Active
C1D826-Jul-2026
C1D1502-Aug-2026
Cycle 2 · RECIST16-Aug-2026

Safety Labs · Pre-dose Validation

Hematology & chemistry · CTCAE v5.0 grading

1 flag · action required
Automated Safety Flag — Grade 2 Neutropenia CTCAE Grade 2

ANC 1.1 K/µL is below the protocol dosing threshold (≥ 1.5 K/µL) required for C1D1 administration. Protocol PS-2041 §6.3 requires a dose modification or dosing delay before study drug is given. Investigator decision required.

ParameterResultUnitsReferenceCTCAEStatus
Hemoglobin12.8g/dL12.0–16.0Within range
WBC4.6K/µL4.0–11.0Within range
ANC (Absolute Neutrophil Count)1.1K/µL1.5–8.0G2Below threshold
Platelets176K/µL150–400Within range
Creatinine0.9mg/dL0.6–1.3Within range
ALT28U/L7–56Within range
Investigator clinical decision
Record the rationale for managing the Grade 2 neutropenia per protocol §6.3.
Decision recorded:

eCOA · Clinical Outcome Assessments

Point-of-care performance status & patient-reported outcomes

Captured
ECOG Performance Status clinician-rated
0Grade 0Fully active, no restriction
1Grade 1Ambulatory, light work restriction
2Grade 2Ambulatory, self-care, no work
Patient Symptom Tracker logged on tablet
FatigueGr 1 · Mild
DyspneaGr 1 · Mild
NauseaGr 0 · None
NeuropathyGr 1 · Mild
Patient Sign-Off validatedSubject 2041-0017 · signed on tablet 07:52 EDT
Cryptographic
e-signature ✓

Infusion & Serial PK Protocol

Study drug administration & pharmacokinetic sampling

Infusion complete
Infusion Tracking PS-2041 study drug · 40 mg/m²
Infusion start19-Jul 10:05:12
Infusion stop19-Jul 11:35:40
Duration90 min 28 s
Rate250 mL/hr
Administered byRN M. Alvarez
Verified vial tracking✓ scanned 10:01
PS-2041-99081-A
Serial PK Draws relative to infusion end
Pre-doseCollected 09:50:04 · aliquot A-01 loggedCompleted
1 h post-infusionCollected 12:35:22 · aliquot A-02 loggedCompleted
2 h post-infusionScheduled window 13:35 (± 10 min)Due in 14 min
Next draw window opens at 13:35 EDT — the nurse is alerted automatically.

Audit Trail & Electronic Signature

21 CFR Part 11 · attributable, time-stamped, tamper-evident

Logging live
Immutable Audit Ledger every action recorded
audit-stream · subject 2041-0017 · C1D1
Investigator Sign-Off secure credentials
I understand this electronic signature is the legally binding equivalent of my handwritten signature, applied to the C1D1 record for Subject 2041-0017.
Record electronically signed
dr.a.okafor@site214.org

Meaning: Investigator review & approval
Signature hash